C Gisselbrecht
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 32
- Genetics 16
- Chronic Lymphocytic Leukemia Research 16
C Gisselbrecht
45 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 63
- Pathology and Forensic Medicine 830
- Genetics 279
- Oncology 692
- Dermatology 144
- Hematology 152
Countries citing papers authored by C Gisselbrecht
This map shows the geographic impact of C Gisselbrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Gisselbrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Gisselbrecht more than expected).
Fields of papers citing papers by C Gisselbrecht
This network shows the impact of papers produced by C Gisselbrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Gisselbrecht. The network helps show where C Gisselbrecht may publish in the future.
Co-authors
The 25 scholars most cited alongside C Gisselbrecht, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | R-CHOP VERSUS R-FC FOLLOWED BY MAINTENANCE WITH RITUXIMAB OR IFN: FIRST RESULTS OF A RANDOMIZED TRIAL FOR ELDERLY PATIENTS WITH MANTLE CELL LYMPHOMA | 2011 | 4 |
| 2 | 2007 | 14 | |
| 3 | 2006 | 67 | |
| 4 | 2004 | 48 | |
| 5 | 2003 | 1 | |
| 6 | 2003 | 1 | |
| 7 | 2002 | 6 | |
| 8 | Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma (NHL) with the ACVBP regimen. A GELA (Groupe d'Etude des Lymphomes de l'Adulte) cohort study on 2849 patients. | 2001 | 4 |
| 9 | 2000 | 24 | |
| 10 | 1999 | 26 | |
| 11 | 1999 | 51 | |
| 12 | 1998 | 35 | |
| 13 | Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93 | 1997 | 7 |
| 14 | 1997 | 15 | |
| 15 | Alternance of chemotherapy does not improve results in aggressive non-Hodgkin's lymphoma: A prospective randomized study on 884 patients LNH87 protocol group 3: A gela study | 1996 | 2 |
| 16 | 1994 | 27 | |
| 17 | Alternating Chemotherapy Does Not Improve Results in Poor-prognosis Aggressive Lymphomas - Lnh87 Protocol Group-3 - a Gela Study | 1993 | 2 |
| 18 | 1993 | 143 | |
| 19 | 1990 | 35 | |
| 20 | 1990 | 207 |
About C Gisselbrecht
C Gisselbrecht is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Hematology and Dermatology, having authored 45 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (32 papers), Chronic Lymphocytic Leukemia Research (16 papers), Viral-associated cancers and disorders (10 papers), Lung Cancer Treatments and Mutations (9 papers), T-cell and Retrovirus Studies (4 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Cancer Treatment and Pharmacology (3 papers) and Cutaneous lymphoproliferative disorders research (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (830 citations), Genetics (279 citations), Oncology (692 citations), Dermatology (144 citations) and Hematology (152 citations). C Gisselbrecht has collaborated with scholars based in France, Germany and Czechia. Frequent co-authors include Bertrand Coiffier, F Reyes, Corinne Haïoun, P.A. Bryon, Pauline Brice, Hans Hagberg, Éric Lepage, F Berger, J Diébold and Nicole Brousse. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Blood, Bone Marrow Transplantation and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.